News

Medical Debt

Several states use taxpayer dollars to help struggling residents pay down medical debt. One is considered a leader of the movement—by critics as well as proponents. 

The Children’s Health Defense, a vaccine-skeptic lobby once chaired by HHS Secretary Robert F. Kennedy Jr., filed a complaint in federal court against the American Academy of Pediatrics, alleging it engaged in systemic corruption. The same day, Texas Attorney General Ken Paxton said his state would be investigating the financial ties between vaccine developers, insurers and pediatricians.

Thumbnail

California’s decision to restrict the use of the title “doctor” in clinical settings underscores a growing disconnect between healthcare policy and the realities of modern care delivery. In an op-ed, health policy professor and former Virginia legislator, Dawn M. Adams, DNP, and Marissa J. Levine, MD, a public health physician and former Virginia health commissioner, argue that rigid physician-centric hierarchies no longer reflect how patients actually receive care.

Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,

The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. 

The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.

The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.

The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

Gene editing software image from Scribe Therapeutics for its STX-1150 drug to treat LDL-C.

Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.

ACC.24 sign American College of Cardiology

The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.

Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business. 

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.

MGMA's Anders Gilberg calls on CMS and Congress to extend telemedicine and highlights the issues involved.

Congress temporarily extended telemedicine provisions until March amid lobby efforts by the Medical Group Management Association (MGMA) and others to make the provisions permanent.

Around the web

Several states use taxpayer dollars to help struggling residents pay down medical debt. One is considered a leader of the movement—by critics as well as proponents.